1. Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors
   Josep Tabernero et al, 2008, JCO CrossRef
2. T-2 Toxin Induces Oxidative Stress, Apoptosis and Cytoprotective Autophagy in Chicken Hepatocytes
   Huadong Yin et al, 2020, Toxins CrossRef
3. Effect of amifostine on sperm DNA fragmentation and testes after radioiodine treatment
   Cigdem Cebi Sen et al, 2017 CrossRef
4. PROX1, a Key Mediator of the Anti-Proliferative Effect of Rapamycin on Hepatocellular Carcinoma Cells
   Sora Kwon et al, 2022, Cells CrossRef
5. mTOR and P70 S6 Kinase Expression in Primary Liver Neoplasms
   Fikret Sahin et al, 2004 CrossRef
6. Stability of Phosphoprotein as a Biological Marker of Tumor Signaling
   Amanda F. Baker et al, 2005 CrossRef
7. Phase I/II Study of the Mammalian Target of Rapamycin Inhibitor Everolimus (RAD001) in Patients with Relapsed or Refractory Hematologic Malignancies
   Karen W.L. Yee et al, 2006 CrossRef
8. Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer
   Guanzhen Yu et al, 2009 CrossRef
9. mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies
   Dániel Sztankovics et al, 2024, Pathol. Oncol. Res. CrossRef